These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24304648)

  • 21. MicroRNA signatures: novel biomarker for colorectal cancer?
    Luo X; Burwinkel B; Tao S; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of aberrantly expressed miRNAs in rectal cancer.
    Li X; Zhang G; Luo F; Ruan J; Huang D; Feng D; Xiao D; Zeng Z; Chen X; Wu W
    Oncol Rep; 2012 Jul; 28(1):77-84. PubMed ID: 22576798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
    Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
    PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
    Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.
    Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
    Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
    Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
    Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
    Chai H; Liu M; Tian R; Li X; Tang H
    Acta Biochim Biophys Sin (Shanghai); 2011 Mar; 43(3):217-25. PubMed ID: 21242194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
    Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancer.
    Dou R; Deng Y; Huang L; Fu S; Tan S; Wang L; Lian L; Fang L; Fan X; Jin G; Liu H; Wang J
    Cancer Lett; 2013 Aug; 336(1):106-13. PubMed ID: 23612070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
    Liu X; Zhang Z; Sun L; Chai N; Tang S; Jin J; Hu H; Nie Y; Wang X; Wu K; Jin H; Fan D
    Carcinogenesis; 2011 Dec; 32(12):1798-805. PubMed ID: 21934092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection.
    Tsai HL; Yang IP; Huang CW; Ma CJ; Kuo CH; Lu CY; Juo SH; Wang JY
    Transl Res; 2013 Oct; 162(4):258-68. PubMed ID: 23933284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
    Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
    Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.
    Lu YC; Chen YJ; Wang HM; Tsai CY; Chen WH; Huang YC; Fan KH; Tsai CN; Huang SF; Kang CJ; Chang JT; Cheng AJ
    Cancer Prev Res (Phila); 2012 Apr; 5(4):665-74. PubMed ID: 22318752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer.
    Liu K; Li G; Fan C; Zhou X; Wu B; Li J
    J Int Med Res; 2011; 39(6):2288-95. PubMed ID: 22289545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-194 as a predictor for adenoma recurrence in patients with advanced colorectal adenoma after polypectomy.
    Wang ZH; Ren LL; Zheng P; Zheng HM; Yu YN; Wang JL; Lin YW; Chen YX; Ge ZZ; Chen XY; Hong J; Fang JY
    Cancer Prev Res (Phila); 2014 Jun; 7(6):607-16. PubMed ID: 24691499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.
    Bandrés E; Cubedo E; Agirre X; Malumbres R; Zárate R; Ramirez N; Abajo A; Navarro A; Moreno I; Monzó M; García-Foncillas J
    Mol Cancer; 2006 Jul; 5():29. PubMed ID: 16854228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor functions of miR-133a in colorectal cancer.
    Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
    Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.